Next Science (ASX:NXS) Total Liabilities : A$7.59 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Total Liabilities?

Next Science's Total Liabilities for the quarter that ended in Dec. 2023 was A$7.59 Mil.

Next Science's quarterly Total Liabilities increased from Dec. 2022 (A$6.56 Mil) to Jun. 2023 (A$17.73 Mil) but then declined from Jun. 2023 (A$17.73 Mil) to Dec. 2023 (A$7.59 Mil).

Next Science's annual Total Liabilities increased from Dec. 2021 (A$4.12 Mil) to Dec. 2022 (A$6.56 Mil) and increased from Dec. 2022 (A$6.56 Mil) to Dec. 2023 (A$7.59 Mil).

Next Science Total Liabilities Historical Data

The historical data trend for Next Science's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Total Liabilities Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

4.84

6.28

4.12

6.56

7.59

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial					4.12	6.83	6.56	17.73	7.59

Next Science Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Next Science's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.732	+	(1.026	+	-0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.822	+	0.009)
	=	7.59

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	26.743	-	19.155
	=	7.59

Next Science's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.732	+	(1.026	+	-0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.822	+	0.009)
	=	7.59

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	26.743	-	19.155
	=	7.59

Next Science Total Liabilities Related Terms

Thank you for viewing the detailed overview of Next Science's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines